nicotinic acid hydrazide has been researched along with Hyperlipemia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aboelez, MO; Abuo-Rahma, GEA; Ahmed, SA; Elhady, OM; Shaykhon, MSA; Shoman, ME | 1 |
1 other study(ies) available for nicotinic acid hydrazide and Hyperlipemia
| Article | Year |
|---|---|
New nicotinic acid-based 3,5-diphenylpyrazoles: design, synthesis and antihyperlipidemic activity with potential NPC1L1 inhibitory activity.
Topics: Animals; Cholesterol; Drug Design; Hydrazines; Hyperlipidemias; Hypolipidemic Agents; Male; Membrane Transport Proteins; Molecular Docking Simulation; Nicotinic Acids; Pyrazoles; Rats, Wistar; Triglycerides | 2021 |